Work

Deucravacitinib as a Novel JAK Inhibitor in the Treatment of Autoimmune Disorders

Year: 2025

Type: article

Study design: Systematic Review

Source: International Journal of Science and Healthcare Research

DOI: 10.52403/ijshr.20250131

Authors: Israt Shilpi, Mahmudur Rahman, Toioba Akter

Institution: Dhaka Medical College and Hospital

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409116236

FWCI:

Cites:

Cited by:

Related to: 10